MOUNTAIN VIEW, Calif. - Friday, 19. January 2024

(BUSINESS WIRE)--inDrive, a global mobility and urban services platform operating across 46 countries, was the world’s second most downloaded ride-hailing app in 2023, retaining this accolade for a second consecutive year, according to data.ai. InDrive also achieved a notable milestone, ranking as the fourth most downloaded application worldwide in the Travel category.

Total downloads of the inDrive app amounted to 66.6 million in 2023, based on Google Play and App Store data (China is iOS only), data.ai said.

inDrive continues to enjoy robust growth as it adds new services including freight, courier and B2B delivery, as well as intercity rides and handyman services, while also expanding its core ridesharing offering to new geographies. In 2023, inDrive launched its services in multiple new locations, including the Miami and South Florida region of the U.S.

While scaling quickly, leveraging its un ... Read more »

• Fourth-quarter revenue of $8.99 billion increased 8% sequentially and 14% year on year
• Fourth-quarter GAAP EPS of $0.77 decreased 1% sequentially and increased 4% year on year
• Fourth-quarter EPS, excluding charges and credits, of $0.86 increased 10% sequentially and 21% year on year
• Fourth-quarter cash flow from operations was $3.02 billion and free cash flow was $2.28 billion
• Board approved a 10% increase in quarterly cash dividend to $0.275 per share
• Full-year revenue of $33.14 billion increased 18% year on year
• Full-year GAAP EPS of $2.91 increased 22% year on year
• Full-year EPS, excluding charges and credits, of $2.98 increased 37% year on year
• Full-year net income attributable to SLB of $4.20 billion increased 22% year on year
• Full-year adjusted EBITDA of $8.11 billion increased 25% year on year
• Full-year cash flow from operations was $6.64 billion and fre ... Read more »

(BUSINESS WIRE) -- Fujirebio Holdings, Inc. and Agappe Diagnostics Ltd today announced that they have entered into an agreement of Contract Development and Manufacturing Organization (CDMO) partnership for Cartridge based CLIA system reagents manufacturing project for the immunology equipment Mispa i60 and Mispa i121. Notably, the analyzers and reagents will be sold under Agappe’s brand, making Agappe the first Indian local company with a complete Chemiluminescence Solution comprising locally manufactured reagents.

In a significant move, Agappe and Fujirebio have revealed plans to launch these products in June 2024. The project has already achieved significant progress, including the signing of a Supply and License Agreement in March 2023. Agappe is at the advanced stages of technical transfer from Fujirebio, enabling them to manufacture Chemiluminescence Reagents using Fujirebio’s technology and materials.

This ... Read more »